Company Filing History:
1 out of 20 
1 out of 131 Years Active: 1996-1998
Title: Juli Feigon: Innovator in HIV Research
Introduction
Juli Feigon is a prominent inventor based in Los Angeles, CA, known for her significant contributions to the field of HIV research. With a total of 2 patents, she has made strides in developing methods to combat HIV-1 reverse transcriptase, a crucial enzyme in the HIV replication process.
Latest Patents
Feigon's latest patents include innovative methods for identifying and preparing DNA ligands to the HIV-1 reverse transcriptase protein. One of her notable inventions involves specific ssDNA ligands to HIV-1 reverse transcriptase identified by the SELEX method. These ligands are designed to inhibit the activity of HIV-1 reverse transcriptase, providing a potential pathway for therapeutic interventions.
Career Highlights
Throughout her career, Juli Feigon has worked with esteemed organizations such as the University Research Corporation and Nexstar Pharmaceuticals, Inc. Her work has been instrumental in advancing the understanding of HIV and developing potential treatments.
Collaborations
Feigon has collaborated with notable colleagues, including Daniel J Schneider and Larry M Gold, further enhancing her research and contributions to the field.
Conclusion
Juli Feigon's innovative work in HIV research and her patented methods for targeting HIV-1 reverse transcriptase highlight her as a key figure in the scientific community. Her contributions continue to pave the way for advancements in HIV treatment and research.